HFB 200604
Alternative Names: HFB 200604 AID; HFB-200604Latest Information Update: 25 Apr 2023
At a glance
- Originator HiFiBiO
- Class Monoclonal antibodies
- Mechanism of Action BTLA protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Autoimmune disorders
Most Recent Events
- 06 Apr 2023 Early research in Autoimmune disorders in USA (Parenteral) (HiFiBiO pipeline, April 2023)